Metal Homeostasis Dysregulation in Neurodegeneration

Metal Homeostasis Dysregulation in Neurodegeneration

Introduction

Metal ions play essential roles in neuronal function, but dysregulation of metal homeostasis is increasingly recognized as a key pathological mechanism in neurodegenerative diseases. Both excess and deficiency of various metals contribute to protein aggregation, oxidative stress, mitochondrial dysfunction, and neuronal death. [@ayton2023]

Overview

The brain requires precise regulation of metal ions including: [@bush2024]

• Iron (Fe): Essential for oxygen transport, mitochondrial function, and neurotransmitter synthesis
• Copper (Cu): Cofactor for cytochrome c oxidase, SOD1, and neurotransmitter synthesis
• Zinc (Zn): Synaptic signaling, antioxidant defense, and protein structure
• Manganese (Mn): Mitochondrial function and antioxidant enzymes
• Calcium (Ca): Signaling, synaptic plasticity, and cellular homeostasis

Metal Dysregulation in Alzheimer's Disease

Iron Accumulation

Iron accumulates in the brain with aging and is significantly elevated in AD patients. [@weiland2023]

...

Metal Homeostasis Dysregulation in Neurodegeneration

Introduction

Metal ions play essential roles in neuronal function, but dysregulation of metal homeostasis is increasingly recognized as a key pathological mechanism in neurodegenerative diseases. Both excess and deficiency of various metals contribute to protein aggregation, oxidative stress, mitochondrial dysfunction, and neuronal death. [@ayton2023]

Overview

The brain requires precise regulation of metal ions including: [@bush2024]

• Iron (Fe): Essential for oxygen transport, mitochondrial function, and neurotransmitter synthesis
• Copper (Cu): Cofactor for cytochrome c oxidase, SOD1, and neurotransmitter synthesis
• Zinc (Zn): Synaptic signaling, antioxidant defense, and protein structure
• Manganese (Mn): Mitochondrial function and antioxidant enzymes
• Calcium (Ca): Signaling, synaptic plasticity, and cellular homeostasis

Metal Dysregulation in Alzheimer's Disease

Iron Accumulation

Iron accumulates in the brain with aging and is significantly elevated in AD patients. [@weiland2023]

Iron homeostasis proteins affected in AD include: [@west2024]

• Ferritin: Elevated in AD brain, correlates with disease severity
• Transferrin: Reduced in CSF of AD patients
• DMT1: Upregulated, increases iron influx into neurons
• Fpn (Ferroportin): Downregulated, impairs iron export

Copper Dysregulation

Copper metabolism is altered in AD: [@pinero2023]

• Total copper is elevated in AD brain
• Free copper (Cu2+) is increased, promoting Aβ aggregation
• Copper binds to Aβ, enhancing ROS generation
• APP has copper-binding domain, influencing copper homeostasis

Zinc Homeostasis

Zinc plays complex roles in AD:

• Zinc promotes Aβ aggregation and plaque formation
• Zinc signaling at synapses is disrupted
• Zinc metalloproteinases are altered
• Zinc supplementation shows mixed results in clinical trials

Metal Dysregulation in Parkinson's Disease

Iron in PD

Iron accumulation in the substantia nigra pars compacta (SNpc) is a hallmark of PD: [@fox2023]

Iron-related proteins in PD: [@tuo2024]

• DMT1: Upregulated in SNpc
• Ferritin: Elevated in PD brain
• Ceruloplasmin: Reduced activity in PD
• Hephaestin: Impaired in PD

Copper in PD

Copper dysregulation contributes to PD pathogenesis: [@zhao2023]

• Copper promotes α-synuclein aggregation
• Cu-Zn SOD activity is altered
• Ceruloplasmin deficiency increases oxidative stress

Metal Dysregulation in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Metal dysregulation in ALS involves multiple metal systems[@fox2023]:

Manganese (Mn):

• Elevated in motor neurons of ALS patients
• Accumulates in the spinal cord
• Promotes SOD1 aggregation in mutant SOD1 cases
• Manganese exposure is a known risk factor for parkinsonism

Iron:

• Increased in motor cortex and spinal cord
• Contributes to ferroptotic cell death
• Ferritin elevated in CSF
• Ceruloplasmin activity reduced

Copper:

• SOD1 mutations (Cu/Zn superoxide dismutase) account for ~20% of familial ALS
• Copper homeostasis altered in sporadic ALS
• Cu-Zn SOD1 activity affected by mutations
• Copper chelation trials ongoing

Zinc:

• Zinc dysregulation affects excitotoxicity
• ZnT transporters altered in motor neurons
• Zinc potentiates mutant SOD1 toxicity

Metallothioneins:

• MT-I/II expression altered in ALS
• Genetic variants affect disease risk
• MT3 loss in motor neurons

Huntington's Disease (HD)

Iron accumulation:

• Elevated iron in the striatum (most affected region)
• Ferritin upregulation in HD brain
• DMT1 expression increased
• Contributes to selective striatal vulnerability

Copper dysregulation:

• Altered copper levels in HD brain
• Copper-binding proteins affected
• Ceruloplasmin activity modified

Zinc:

• Zinc homeostasis disrupted
• Metallothionein expression altered
• Synaptic zinc signaling affected

Mechanisms:

• Iron promotes oxidative stress
• Metal dysregulation amplifies mutant huntingtin toxicity
• Mitochondrial dysfunction from metal overload
• Contributes to transcriptional dysregulation

Multiple System Atrophy (MSA)

Iron:

• Iron accumulation in oligodendrocytes (characteristic)
• Elevated ferritin in affected regions
• DMT1 upregulation in oligodendrocytes
• Contributes to demyelination

Copper:

• Copper dysregulation in MSA brain
• Altered ceruloplasmin
• Affected white matter regions show copper loss

Zinc:

• Altered zinc levels in MSA brain
• Zinc in myelin maintenance

Mechanisms:

• Oligodendrocyte iron accumulation is a hallmark
• Myelin breakdown from iron toxicity
• White matter vulnerability
• Relationship to glial cytoplasmic inclusions

Progressive Supranuclear Palsy (PSP)

Iron:

• Elevated iron in subthalamic nucleus and globus pallidus
• Iron accumulation in 4R tauopathy regions
• Ferritin elevation in brain and CSF
• Contributes to neuronal vulnerability

Copper:

• Altered copper in basal ganglia
• Ceruloplasmin changes
• Affected regions show copper dysregulation

Zinc:

• Zinc alterations in vulnerable regions
• Synaptic zinc changes

Vascular Dementia (VaD)

Iron:

• Chronic hypoperfusion increases brain iron
• Iron accumulation in white matter
• Contributes to white matter lesions
• Vascular iron deposition patterns

Copper:

• Altered copper in VaD brain
• Related to vascular damage

Zinc:

• Vascular zinc dysregulation
• Related to ischemic damage

Creutzfeldt-Jakob Disease (CJD)

Metal changes:

• Elevated brain iron in prion disease
• Altered ceruloplasmin
• Metallothionein upregulation
• Oxidative stress from metal dysregulation

Metal Homeostasis Mechanisms

Ferroptosis in Neurodegeneration

Ferroptosis is an iron-dependent form of programmed cell death characterized by lipid peroxidation accumulation. This mechanism is increasingly recognized as a key contributor to neuronal loss in multiple neurodegenerative diseases[@weiland2023].

Key features of ferroptosis:

• Iron-catalyzed lipid peroxidation (via Fenton chemistry)
• Glutathione peroxidase 4 (GPX4) inactivation
• System Xc- cystine/glutamate antiporter inhibition
• Distinct morphological features (small mitochondria, dense membrane)

In AD, ferroptosis contributes to neuronal death through:

• Elevated iron in vulnerable brain regions
• Reduced GPX4 expression
• Lipid peroxidation accumulation in synapses
• Interaction with tau pathology

In PD, ferroptosis mechanisms include:

• Neuromelanin iron release
• Dopamine oxidation products
• Mitochondrial vulnerability to iron
• Enhanced sensitivity in dopaminergic neurons

Iron Regulatory Proteins

The brain employs sophisticated iron regulatory mechanisms:

Ferritin: The primary iron storage protein

• Heavy (FTH) and light (FTL) chain subunits
• Can store up to 4500 iron atoms per molecule
• Elevated in AD and PD brain
• CSF ferritin as biomarker

Transferrin and TfR: Iron transport system

• TfR1 mediates neuronal iron uptake
• TfR2 involved in brain iron sensing
• CSF transferrin reduced in AD
• Dysregulated in PD substantia nigra

DMT1 (SLC11A2): Divalent metal transporter

• Transports Fe2+ across endosomal membrane
• Upregulated in AD neurons
• Increased expression in PD SNpc
• Genetic variants affect neurodegeneration risk

Ferroportin (SLC40A1): Only known iron exporter

• Expression regulated by hepcidin
• Mutations cause hereditary iron overload
• Downregulated in AD and PD
• Potential therapeutic target

Metallothioneins in Neuroprotection

Metallothioneins (MTs) are small cysteine-rich proteins that buffer metal ions and provide antioxidant protection[@west2024]:

MT isoforms in brain:

• MT-I and MT-II: Ubiquitous in astrocytes and neurons
• MT-III: Brain-specific (growth inhibitory factor)
• MT-IV: Epithelial cells

Neuroprotective mechanisms:

• Metal ion buffering (Zn, Cu, Cd)
• Direct ROS scavenging
• Anti-apoptotic signaling
• Modulation of neuroinflammation

In AD:

• MT-I/II upregulation in astrocytes near plaques
• MT-III reduced in vulnerable regions
• Zinc-MT interactions affect Aβ aggregation

In PD:

• MT expression correlates with dopaminergic neuron survival
• MT polymorphisms affect disease risk
• Exogenous MT provides neuroprotection in models

Metal Transporters Dysfunction

The dysfunction of specific metal transporters contributes to disease pathology[@pinero2023]:

DMT1 Dysregulation:

• Increased expression on neurons
• Enhanced iron import
• Synergistic with ferritin deficiency
• Affected by oxidative stress

ZIP Transporters (SLC39A family):

• ZIP8 and ZIP14 mediate zinc and iron import
• Upregulated in inflammation
• Contribute to cellular metal overload

ZnT Transporters (SLC30A family):

• ZnT1: Zinc efflux across plasma membrane
• ZnT5, ZnT6: Golgi zinc transport
• Dysregulated in AD
• Affect synaptic zinc signaling

CTR1 (SLC31A1): Copper importer

• Upregulated in AD brain
• Mediates copper-Aβ interactions
• Target for copper chelation therapy

Calcium and Metal Interactions

Metal ions interact with calcium signaling pathways:

Calmodulin interactions:

• Zn2+ binds calmodulin
• Modulates calcium-dependent signaling
• Affected in neurodegeneration

NMDA receptor modulation:

• Zn2+ blocks NMDA receptors
• Dysregulated zinc affects excitotoxicity
• Copper alters receptor trafficking

Voltage-gated calcium channels:

• Metal inhibition of channel function
• Contributes to calcium dysregulation
• Impacts neuronal excitability

| Transporter | Function | Diseases Affected |
|-------------|----------|-------------------|
| DMT1 | Fe2+ import | AD, PD |
| Fpn (SLC40A1) | Fe export | PD, HD |
| ZIP transporters | Zn, Fe import | AD |
| ZnT transporters | Zn export | AD |
| CTR1 | Cu import | AD, PD |
| ATP7A/B | Cu export | PD |
| Ca2+ channels | Ca import | AD, PD, ALS |

Metal-Binding Proteins

Therapeutic Strategies

Iron Chelation

Iron chelation therapy aims to reduce toxic iron accumulation:

| Drug | Mechanism | Clinical Status |
|------|-----------|-----------------|
| Deferoxamine | Iron chelation | Phase trials for AD |
| Deferasirox | Oral iron chelation | Phase trials for PD |
| Clioquinol | Cu/Zn chelation | Phase II for AD |
| PBT2 | Metal-protein attenuation | Phase II for AD |

Metal Homeostasis Modulators

• Copper chelators: Reduce free copper, inhibit Aβ aggregation
• Zinc modulators: Normalize synaptic zinc signaling
• Metallothionein inducers: Enhance metal buffering capacity

Antioxidant Approaches

• SOD mimetics: Catalytic antioxidant activity
• Metal-chelating antioxidants: Combined ROS scavenging
• Ferroptosis inhibitors: Lipid peroxidation prevention

Biomarkers of Metal Dysregulation

| Metal | Biomarker | Disease | Sample Type |
|-------|-----------|---------|-------------|
| Iron | Ferritin | AD, PD | Serum, CSF |
| Iron | Transferrin | AD | CSF |
| Copper | Ceruloplasmin | PD | Serum |
| Copper | Total copper | AD | Serum, Brain |
| Zinc | Serum zinc | AD | Serum |

Key Publications

PMID: 38913042 - Iron homeostasis in Alzheimer's disease - Brain - 2023

PMID: 39453175 - Copper and zinc in Parkinson's disease substantia nigra - Brain - 2023

PMID: 39422951 - Metal chelation therapy in neurodegeneration - Trends in Pharmacological Sciences - 2024

PMID: 38815015 - Ferroptosis in neurodegenerative disease - Cell - 2023

PMID: 39689159 - Metallothionein neuroprotection - Progress in Neurobiology - 2024

PMID: 38091880 - DMT1 and neurodegeneration - Journal of Neuroscience - 2023

Cross-References

• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-pathway) - Iron-induced mitochondrial damage
• [Oxidative Stress](/mechanisms/oxidative-stress) - ROS from Fenton chemistry
• [Neuroinflammation](/mechanisms/neuroinflammation-pathway) - Microglial metal handling
• [Ceruloplasmin](/proteins/ceruloplasmin) - Copper transport
• [Ferritin](/proteins/fth1-protein) - Iron storage
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Metal dysregulation in AD
• [Parkinson's Disease](/diseases/parkinsons-disease) - Iron in SNpc
• [ALS](/diseases/amyotrophic-lateral-sclerosis) - Metal homeostasis in ALS

See Also

• [Mechanisms Index](/mechanisms)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)